Table 2.
Abortion outcomesa and unplanned encounters, n (%)
| N = 1390 | |
|---|---|
| Neither medication taken, or medications taken after miscarriage diagnosis Lost to follow-up Known abortion outcome |
47 (3.4) 186 (13.4) 1157 (83.2) |
|
Abortion outcome at last contact Complete abortion without surgical intervention Surgical intervention Reason: ongoing pregnancy Ongoing pregnancy; carrying to term or unknownb |
n = 1157 1103 (95.3) 47 (4.1) 14 (1.2) 7 (0.6) |
|
Method used in outcome assessment among complete abortions with no surgical intervention Facility-based test (ultrasound, serum HCG, and/orpelvic exam)c No facility-based test Urine pregnancy test (UPT)d Patient history only |
n = 1103 396 (35.9) 707 (64.1) 647 (58.7) 60 (5.4) |
|
Abortion-related unplanned encounterse Emergency room (ER)/urgent care Other outpatient visit Serious Adverse Events Hospitalization Transfusionf |
n=1173 70 (6.0) 92 (7.8) 10 (0.9) 8 (0.7) 5 (0.4) |
Includes multiple abortions by same individual.
Includes one abortion where participant threw up mifepristone after 10 minutes and then decided to continue pregnancy.
Outcomes assessed with facility-based tests may also have utilized UPTs and/or patient history.
In 3 cases, the UPT result(s) were positive and the diagnosis of complete abortion was made by patient history only.
Denominator includes abortions with known outcome or any unplanned encounters that occurred after study consent was signed. Does not include encounters for lab tests, anti-D immunoglobulin, or contraception alone. Includes 1 hospitalization, 4 ER visits, and 12 other outpatient encounters that occurred prior to taking (or deciding not to take) mifepristone. Abortions may be included in more than one category.
Two of the transfusions occurred in an ER and are not included in Hospitalization.